Probing contacts of inhibitor locked in transition states in the catalytic triad of DENV2 type serine protease and its mutants by 1H, 19F and 15 N NMR spectroscopy

[1]  J. Hardy,et al.  Cysteine Disulfide Traps Reveal Distinct Conformational Ensembles in Dengue Virus NS2B-NS3 Protease. , 2018, Biochemistry.

[2]  P. Agback,et al.  Direct evidence of a low barrier hydrogen bond in the catalytic triad of a Serine protease , 2018, Scientific Reports.

[3]  Joyce V. B. Borba,et al.  The A–Z of Zika drug discovery , 2018, Drug Discovery Today.

[4]  Gaohua Liu,et al.  Inhibitor Bound Dengue NS2B-NS3pro Reveals Multiple Dynamic Binding Modes. , 2018, Biochemistry.

[5]  I. Henderson,et al.  Co-refolding of a functional complex of Dengue NS3 protease and NS2B co-factor domain and backbone resonance assignment by solution NMR. , 2017, Protein expression and purification.

[6]  T. Keller,et al.  Structural Dynamics of Zika Virus NS2B-NS3 Protease Binding to Dipeptide Inhibitors. , 2017, Structure.

[7]  R. Bartenschlager,et al.  Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology. , 2017, Journal of medicinal chemistry.

[8]  P. Frey,et al.  Serine Protease Catalysis: A Computational Study of Tetrahedral Intermediates and Inhibitory Adducts. , 2016, The journal of physical chemistry. B.

[9]  Christoph Nitsche,et al.  Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets. , 2016, Journal of the American Chemical Society.

[10]  M. Mayzel,et al.  Backbone Assignment of the MALT1 Paracaspase by Solution NMR , 2016, PloS one.

[11]  G. Otting,et al.  Capturing Conformational States in Proteins Using Sparse Paramagnetic NMR Data , 2015, PloS one.

[12]  P. Achermann,et al.  Impaired Postural Control in Healthy Men at Moderate Altitude (1630 M and 2590 M): Data from a Randomized Trial , 2015, PloS one.

[13]  Christoph Nitsche,et al.  Biochemistry and medicinal chemistry of the dengue virus protease. , 2014, Chemical reviews.

[14]  G. Otting,et al.  Binding mode of the activity‐modulating C‐terminal segment of NS2B to NS3 in the dengue virus NS2B–NS3 protease , 2014, The FEBS journal.

[15]  Y. Bi,et al.  Backbone 1H, 13C and 15N resonance assignments of dengue virus NS2B–NS3p in complex with aprotinin , 2013, Biomolecular NMR assignments.

[16]  Rong Li,et al.  NMR Analysis of a Novel Enzymatically Active Unlinked Dengue NS2B-NS3 Protease Complex* , 2013, The Journal of Biological Chemistry.

[17]  J. Malthouse,et al.  The importance of tetrahedral intermediate formation in the catalytic mechanism of the serine proteases chymotrypsin and subtilisin , 2016 .

[18]  A. Sokaribo,et al.  One-step amino acid selective isotope labeling of proteins in prototrophic Escherichia coli strains. , 2012, Analytical biochemistry.

[19]  V. Dembitsky,et al.  Boron containing compounds as protease inhibitors. , 2012, Chemical reviews.

[20]  J. Isaksson,et al.  Probing water-protein contacts in a MMP-12/CGS27023A complex by nuclear magnetic resonance spectroscopy , 2012, Journal of biomolecular NMR.

[21]  G. Otting,et al.  Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts. , 2011, Journal of the American Chemical Society.

[22]  Tim J Stevens,et al.  DANGLE: A Bayesian inferential method for predicting protein backbone dihedral angles and secondary structure. , 2010, Journal of magnetic resonance.

[23]  R. Prosser,et al.  Approaches for the measurement of solvent exposure in proteins by 19F NMR , 2009, Journal of biomolecular NMR.

[24]  S. Withers,et al.  Probing electrostatic interactions along the reaction pathway of a glycoside hydrolase: histidine characterization by NMR spectroscopy. , 2007, Biochemistry.

[25]  Zheng Yin,et al.  Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus , 2006, Nature Structural &Molecular Biology.

[26]  Helena Berglund,et al.  Improved solubility of TEV protease by directed evolution. , 2006, Journal of biotechnology.

[27]  L. Polgár.  The catalytic triad of serine peptidases , 2005, Cellular and Molecular Life Sciences CMLS.

[28]  Wayne Boucher,et al.  The CCPN data model for NMR spectroscopy: Development of a software pipeline , 2005, Proteins.

[29]  L. Hedstrom.  Serine protease mechanism and specificity. , 2002, Chemical reviews.

[30]  R. London,et al.  Formation of a trypsin-borate-4-aminobutanol ternary complex. , 2002, Biochemistry.

[31]  T. Harris,et al.  Structural Basis of Perturbed pKa Values of Catalytic Groups in Enzyme Active Sites , 2002, IUBMB life.

[32]  W. Bachovchin,et al.  Review: Contributions of NMR spectroscopy to the study of hydrogen bonds in serine protease active sites , 2001 .

[33]  A. Eletsky,et al.  TROSY NMR with partially deuterated proteins , 2001, Journal of biomolecular NMR.

[34]  J. Gesell,et al.  Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex. , 2001, Journal of molecular biology.

[35]  P. Frey,et al.  The deuterium isotope effect on the NMR signal of the low-barrier hydrogen bond in a transition-state analog complex of chymotrypsin. , 2000, Biochemical and biophysical research communications.

[36]  T. Schulte-Herbrüggen,et al.  Clean TROSY: compensation for relaxation-induced artifacts. , 2000, Journal of magnetic resonance.

[37]  R. Yusof,et al.  Purified NS2B/NS3 Serine Protease of Dengue Virus Type 2 Exhibits Cofactor NS2B Dependence for Cleavage of Substrates with Dibasic Amino Acids in Vitro* , 2000, The Journal of Biological Chemistry.

[38]  S. Grzesiek,et al.  Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain , 2000, The EMBO journal.

[39]  W. Huskey,et al.  Hydrogen Bonding to Active-Site Histidine in Peptidyl Boronic Acid Inhibitor Complexes of Chymotrypsin and Subtilisin: Proton Magnetic Resonance Assignments and H/D Fractionation , 1999 .

[40]  P. Frey,et al.  Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin. , 1998, Biochemistry.

[41]  V. Stoll,et al.  Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes. , 1998, Biochemistry.

[42]  G. Kuno,et al.  Phylogeny of the Genus Flavivirus , 1998, Journal of Virology.

[43]  R. Riek,et al.  Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Frey,et al.  A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond. , 1997, Biochemistry.

[45]  W. Bachovchin,et al.  15N and 1H NMR spectroscopy of the catalytic histidine in chloromethyl ketone-inhibited complexes of serine proteases. , 1996, Biochemistry.

[46]  P. Frey,et al.  A low-barrier hydrogen bond in the catalytic triad of serine proteases. , 1994, Science.

[47]  W. Cleland,et al.  Low-barrier hydrogen bonds and enzymic catalysis. , 1994, Science.

[48]  John Alan Gerlt,et al.  An explanation for rapid enzyme-catalyzed proton abstraction from carbon acids: importance of late transition states in concerted mechanisms , 1993 .

[49]  W. Bachovchin,et al.  Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by 1H NMR spectroscopy. , 1992, Biochemistry.

[50]  J. P. Malthouse,et al.  A study of the stabilization of tetrahedral adducts by trypsin and delta-chymotrypsin. , 1992, The Biochemical journal.

[51]  C. Lai,et al.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins , 1991, Journal of virology.

[52]  D. Ringe,et al.  Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors. , 1990, Biochemistry.

[53]  D. Agard,et al.  Structural analysis of specificity: alpha-lytic protease complexes with analogues of reaction intermediates. , 1990, Biochemistry.

[54]  E. Meyer,et al.  Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate. , 1989, Biochemistry.

[55]  D. Agard,et al.  Structural analysis of specificity: .alpha.-lytic protease complexes with analogs of reaction intermediates , 1989 .

[56]  S. O. Smith,et al.  Crystal versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine protease complex in the crystalline state. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[57]  W. Bachovchin,et al.  Nitrogen-15 NMR spectroscopy of the catalytic-triad histidine of a serine protease in peptide boronic acid inhibitor complexes. , 1988, Biochemistry.

[58]  D. Agard,et al.  Serine protease mechanism: structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid. , 1987, Biochemistry.

[59]  T. Liang,et al.  Complex of alpha-chymotrypsin and N-acetyl-L-leucyl-L-phenylalanyl trifluoromethyl ketone: structural studies with NMR spectroscopy. , 1987, Biochemistry.

[60]  David Beer,et al.  Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead. , 2006, Bioorganic & medicinal chemistry letters.

[61]  Bradley D. Smith,et al.  11B NMR studies of an aryl boronic acid bound to chymotrypsin and subtilisin , 1991 .

[62]  C. Rice,et al.  Flavivirus genome organization, expression, and replication. , 1990, Annual review of microbiology.